Candidate gene case-control studies

被引:19
作者
Daly, AK [1 ]
机构
[1] Newcastle Univ, Pharmacogenet Grp, Sch Clin & Lab Sci, Sch Med, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England
关键词
cancer; candidate gene; DNA repair; single nucleotide polymorphism; xenobiotic metabolism;
D O I
10.1517/phgs.4.2.127.22629
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Two main approaches to the identification of genes are involved in polygenic diseases. Use of family studies has generally been the preferred approach up until recently, but this is only feasible if the genetic component of the disease is relatively strong and DNA samples are available from other family members. Population case-control studies are useful both as an alternative and an adjunct to family studies. These can involve either whole genome scanning or candidate gene approaches. While whole genome scanning is likely to be widely used in the future once more information on genome-wide single nucleotide polymorphism distributions is available, at present, candidate gene studies are more feasible. When performing candidate gene case-control studies factors such as study design, methods for recruitment of case and controls, selection of candidate genes, functional significance of polymorphisms chosen for study and statistical analysis require close attention to ensure that only genuine associations are detected. Some examples of the successful use of candidate gene case-control studies are discussed and, to illustrate some potential problems in the design and interpretation of association studies, some specific examples of association studies on cancer are considered.
引用
收藏
页码:127 / 139
页数:13
相关论文
共 110 条
[41]   Analysis of CYP2D6 expression in human lung: Implications for the association between CYP2D6 activity and susceptibility to lung cancer [J].
Kivisto, KT ;
Griese, KU ;
Stuven, T ;
Fritz, P ;
Friedel, G ;
Kroemer, HK ;
Zanger, UM .
PHARMACOGENETICS, 1997, 7 (04) :295-302
[42]  
KOURI RE, 1982, CANCER RES, V42, P5030
[43]   Variants in DNA double-strand break repair genes and breast cancer susceptibility [J].
Kuschel, B ;
Auranen, A ;
McBride, S ;
Novik, KL ;
Antoniou, A ;
Lipscombe, JM ;
Day, NE ;
Easton, DF ;
Ponder, BAJ ;
Pharoah, PDP ;
Dunning, A .
HUMAN MOLECULAR GENETICS, 2002, 11 (12) :1399-1407
[44]   Single nucleotide polymorphism libraries: why and how are we building them? [J].
Kwok, PY ;
Gu, ZJ .
MOLECULAR MEDICINE TODAY, 1999, 5 (12) :538-543
[45]  
Le Marchand L, 1998, CANCER RES, V58, P4858
[46]  
Le Marchand L, 2000, CANCER EPIDEM BIOMAR, V9, P181
[47]  
Le Marchand L, 2002, CANCER EPIDEM BIOMAR, V11, P409
[48]  
Le Marchand L, 2001, CANCER EPIDEM BIOMAR, V10, P1259
[49]   Microsomal epoxide hydrolase polymorphisms and lung cancer risk: a quantitative review [J].
Lee, WJ ;
Brennan, P ;
Boffetta, P ;
London, SJ ;
Benhamou, S ;
Rannug, A ;
To-Figueras, J ;
Ingelman-Sundberg, M ;
Shields, P ;
Gaspari, L ;
Taioli, E .
BIOMARKERS, 2002, 7 (03) :230-241
[50]   Isothiocyanates, glutathione S-transferase M1 and T1 polymorphisms, and lung-cancer risk: a prospective study of men in Shanghai, China [J].
London, SJ ;
Yuan, JM ;
Chung, FL ;
Gao, YT ;
Coetzee, GA ;
Ross, RK ;
Yu, MC .
LANCET, 2000, 356 (9231) :724-729